Cargando…

Potential Cost-Effectiveness of a New Infant Tuberculosis Vaccine in South Africa - Implications for Clinical Trials: A Decision Analysis

Novel tuberculosis vaccines are in varying stages of pre-clinical and clinical development. This study seeks to estimate the potential cost-effectiveness of a BCG booster vaccine, while accounting for costs of large-scale clinical trials, using the MVA85A vaccine as a case study for estimating poten...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ditkowsky, Jared B., Schwartzman, Kevin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893082/ https://www.ncbi.nlm.nih.gov/pubmed/24454706 http://dx.doi.org/10.1371/journal.pone.0083526

Ejemplares similares

Modelling the cost-effectiveness of a new infant vaccine to prevent tuberculosis disease in children in South Africa
por: Channing, Liezl, et al.
Publicado: (2014)

Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study
por: Tseng, Chia-Lin, et al.
Publicado: (2011)

Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness
por: Nsengiyumva, Ntwali Placide, et al.
Publicado: (2022)

Costs of seasonal influenza vaccination in South Africa
por: Fraser, Heather, et al.
Publicado: (2022)

Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study
por: Verguet, Stéphane, et al.
Publicado: (2017)

Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis
por: Jayawardana, Sahan, et al.
Publicado: (2022)

Cost-effectiveness of routine adolescent vaccination with an M72/AS01(E)-like tuberculosis vaccine in South Africa and India
por: Harris, Rebecca C., et al.
Publicado: (2022)

What is the Cost of Diagnosis and Management of Drug Resistant Tuberculosis in South Africa?
por: Pooran, Anil, et al.
Publicado: (2013)

The cost and cost implications of implementing the integrated chronic disease management model in South Africa
por: Lebina, Limakatso, et al.
Publicado: (2020)

Cost-benefit analysis of Chlamydia trachomatis screening in pregnant women in a high burden setting in the United States
por: Ditkowsky, Jared, et al.
Publicado: (2017)

Interactions between helminths and tuberculosis infections: Implications for tuberculosis diagnosis and vaccination in Africa
por: Cadmus, Simeon I., et al.
Publicado: (2020)

Estimating a cost-effectiveness threshold for health care decision-making in South Africa
por: Edoka, Ijeoma P, et al.
Publicado: (2020)

Tuberculosis Prevention in South Africa
por: Knight, Gwenan M., et al.
Publicado: (2015)

SARS-CoV-2 Infection and Associated Rates of Diabetic Ketoacidosis in a New York City Emergency Department
por: Ditkowsky, Jared, et al.
Publicado: (2021)

Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa
por: Reddy, Krishna P., et al.
Publicado: (2021)

Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
por: Michaeli, Daniel Tobias, et al.
Publicado: (2022)

Clinical outcomes and cost-effectiveness of COVID-19 vaccination in South Africa
por: Reddy, Krishna P., et al.
Publicado: (2021)

Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa
por: van Rensburg, Craig, et al.
Publicado: (2019)

Strengthening health systems to improve the value of tuberculosis diagnostics in South Africa: A cost and cost-effectiveness analysis
por: Foster, Nicola, et al.
Publicado: (2021)

Evaluating the potential costs and impact of digital health technologies for tuberculosis treatment support
por: Nsengiyumva, Ntwali Placide, et al.
Publicado: (2018)

Audit of amylase and lipase requests in suspected acute pancreatitis and cost implications, South Africa
por: Cook, Annie E., et al.
Publicado: (2022)

The Case for Adolescent HIV Vaccination in South Africa: A Cost-Effectiveness Analysis
por: Moodley, Nishila, et al.
Publicado: (2016)

Financing and cost-effectiveness analysis of public-private partnerships: provision of tuberculosis treatment in South Africa
por: Sinanovic, Edina, et al.
Publicado: (2006)

Comparison of laboratory costs of rapid molecular tests and conventional diagnostics for detection of tuberculosis and drug-resistant tuberculosis in South Africa
por: Shah, Maunank, et al.
Publicado: (2013)

Complexity and evidence in health sector decision-making: lessons from tuberculosis infection prevention in South Africa
por: Perera, Shehani, et al.
Publicado: (2022)

Infant mortality in South Africa - distribution, associations and policy implications, 2007: an ecological spatial analysis
por: Sartorius, Benn KD, et al.
Publicado: (2011)

Immunodeficiency-associated Vaccine-Derived Poliovirus Type 3 in Infant, South Africa, 2011
por: Gumede, Nicksy, et al.
Publicado: (2012)

Maternal and Infant Outcomes Among Pregnant Women Treated for Multidrug/Rifampicin-Resistant Tuberculosis in South Africa
por: Loveday, Marian, et al.
Publicado: (2020)

The potential impact and cost-effectiveness of tobacco reduction strategies for tuberculosis prevention in Canadian Inuit communities
por: N’Diaye, Dieynaba S., et al.
Publicado: (2019)

428. Mobile Phone Access and Comfort: Implications for HIV and Tuberculosis Care in India and South Africa
por: Cox, Sarah N, et al.
Publicado: (2018)

Review of preventative HIV vaccine clinical trials in South Africa
por: Laher, Fatima, et al.
Publicado: (2020)

Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation
por: Vassall, Anna, et al.
Publicado: (2017)

The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia
por: de Boer, Pieter T., et al.
Publicado: (2018)

Bedaquiline-based treatment for extensively drug-resistant tuberculosis in South Africa: A cost-effectiveness analysis
por: Fekadu, Ginenus, et al.
Publicado: (2022)

Tuberculosis screening of travelers to higher-incidence countries: A cost-effectiveness analysis
por: Tan, Michael, et al.
Publicado: (2008)

Novel Cause of Tuberculosis in Meerkats, South Africa
por: Parsons, Sven D.C., et al.
Publicado: (2013)

Challenges for controlling bovine tuberculosis in South Africa
por: Arnot, Luke F., et al.
Publicado: (2020)

Ongoing Trials of Simplified Antibiotic Regimens for the Treatment of Serious Infections in Young Infants in South Asia and Sub-Saharan Africa: Implications for Policy
por: Esamai, Fabian, et al.
Publicado: (2013)

Application of provincial data in mathematical modelling to inform sub-national tuberculosis program decision-making in South Africa
por: Hippner, Piotr, et al.
Publicado: (2019)

Is Antiretroviral Therapy Cost-Effective in South Africa?
por: Braithwaite, R. Scott, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_vn3tuk45pputlk21cj4d0t0crv